Pregnancy complications in PCOS.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Best practice & research. Clinical endocrinology & metabolism

• Publication date

  2006-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.BEEM.2006.03.009PMID 16772158
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome.

  2007cited by this paper
• Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial

  2006cited by this paper
• Drugs for anovulatory infertility in polycystic ovary syndrome

  2006cited by this paper
• Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome.

  2006cited by this paper
• Metformin administration improves endothelial function in women with polycystic ovary syndrome.

  2005cited by this paper
• Plasminogen activator inhibitor 1 and miscarriage after metformin treatment and laparoscopic ovarian drilling in patients with polycystic ovary syndrome.

  2005cited by this paper
• Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study.

  2005cited by this paper
• Birth weight in offspring of mothers with polycystic ovarian syndrome.

  2005influential reference
• Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome.

  2005cited by this paper
• Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy.

  2004cited by this paper
• Prevalence of gestational diabetes mellitus and pregnancy outcomes in Asian women with polycystic ovary syndrome

  2004cited by this paper
• Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial.

  2004cited by this paper
• The effect of different hormone therapies on integrin expression and pinopode formation in the human endometrium: a controlled study.

  2003cited by this paper
• Assessment of glucose tolerance and pregnancy outcome of polycystic ovary patients

  2003cited by this paper
• Impact of Insulin Resistance on Pregnancy Complications and Outcome in Women with Polycystic Ovary Syndrome

  2003cited by this paper
• Body size from birth to adulthood as a predictor of self-reported polycystic ovary syndrome symptoms

  2003cited by this paper
• Pregnancy outcome in women with PCOS and in controls matched by age and weight.

  2003influential reference
• Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial.

  2002cited by this paper
• Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome.

  2002cited by this paper
• Effects of metformin on early pregnancy loss in the polycystic ovary syndrome

  2002cited by this paper
• Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin.

  2002cited by this paper
• Early pregnancy loss following assisted reproductive technology treatment.

  2002cited by this paper
• Obesity increases the risk of spontaneous abortion during infertility treatment.

  2002cited by this paper
• Polycystic ovarian syndrome and the risk of spontaneous abortion following assisted reproductive technology treatment.

  2001cited by this paper
• Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome.

  2001cited by this paper
• [Prevalence of metabolic disorders among family members of patients with polycystic ovary syndrome].

  2001cited by this paper
• Metabolic and steroidogenic alterations related to increased frequency of polycystic ovaries in women with a history of gestational diabetes.

  2001cited by this paper
• Obstetric outcome in women with polycystic ovarian syndrome.

  2001cited by this paper
• Prevalencia familiar de patologas metablicas en pacientes con sndrome de ovario poliqustico

  2001cited by this paper
• Polycystic ovary disease and the risk of pregnancy-induced hypertension.

  2000cited by this paper
• The Prevalence of Polycystic Ovaries in Women with a History of Gestational Diabetes

  2000cited by this paper
• Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome.

  1999cited by this paper
• The fetal insulin hypothesis: an alternative explanation of the association of low birthweight with diabetes and vascular disease.

  1999cited by this paper
• Impaired glucose tolerance in pregnant women with polycystic ovary syndrome.

  1999cited by this paper
• Are women with polycystic ovary syndrome at an increased risk of pregnancy-induced hypertension and/or preeclampsia?

  1999cited by this paper
• Polycystic Ovaries in Women With Gestational Diabetes

  1998cited by this paper
• Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment.

  1998cited by this paper
• Adverse effects of luteinizing hormone on fertility: fact or fantasy.

  1998cited by this paper
• Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth.

  1998cited by this paper
• High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with previous gestational diabetes mellitus.

  1998cited by this paper
• Modern use of clomiphene citrate in induction of ovulation.

  1997cited by this paper
• Pregnancy in infertile PCOD patients. Complications and outcome.

  1997cited by this paper
• Infertility: Incidence of spontaneous abortion in clomiphene pregnancies

  1996cited by this paper
• Incidence of spontaneous abortion in clomiphene pregnancies.

  1996cited by this paper
• Studies on the cytogenetic and endocrinologic background of spontaneous abortion.

  1996cited by this paper
• The importance of endogenous feedback for monofollicular growth in low-dose step-up ovulation induction with follicle-stimulating hormone in polycystic ovary syndrome: a randomized study.

  1996cited by this paper
• Laparoscopic ovarian diathermy: an effective treatment for anti‐oestrogen resistant anovulatory infertility in women with the polycystic ovary syndrome

  1993cited by this paper
• Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome.

  1993cited by this paper
• In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome.

  1993cited by this paper
• Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin.

  1993cited by this paper
• Laparoscopic ovarian diathermy: An effective treatment for anti‐estrogen resistant anovulatory infertility in women with the polycystic ovary syndrome

  1993cited by this paper
• Association of moderate obesity with a poor pregnancy outcome in women with polycystic ovary syndrome treated with low dose gonadotrophin

  1992cited by this paper
• Baillière's clinical obstetrics and gynaecology

  1991cited by this paper
• Combined luteinizing hormone releasing hormone analogue and exogenous gonadotrophins for the treatment of infertility associated with polycystic ovaries.

  1990cited by this paper
• HORMONAL PROFILES FOLLOWING CLOMIPHENE CITRATE THERAPY IN CONCEPTION AND NONCONCEPTION CYCLES

  1990cited by this paper
• Hypersecretion of luteinising hormone, infertility, and miscarriage.

  1990cited by this paper
• Somatotrophic receptors in hepatic tissue of the developing male pig.

  1989cited by this paper
• Influence of serum luteinising hormone concentrations on ovulation, conception, and early pregnancy loss in polycystic ovary syndrome.

  1988cited by this paper
• Recurrent early miscarriage and polycystic ovaries.

  1988cited by this paper
• Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales.

  1986cited by this paper
• High incidence of preeclamptic toxemia in patients with polycystic ovarian disease.

  1982cited by this paper
• Further clinical experience with clomiphene citrate.

  1968cited by this paper

• Effects of Low Molecular Weight Heparin on Early Pregnancy Loss in Women With Polycystic Ovary Syndrome

  2025cites this paper
• ACCEPT Group Condensed Position Paper on the Management of Recurrent Pregnancy Loss

  2025cites this paper
• Risk of Abortion and Ectopic Pregnancy in Women with a History of Polycystic Ovary Syndrome: A Nationwide Population-Based Cohort Study

  2025cites this paper
• Fetomaternal Outcome in Women With Gestational Diabetes Mellitus With and Without Polycystic Ovary Syndrome: A Comparative Approach

  2025cites this paper
• Luteinizing Hormone Variability in Polycystic Ovary Syndrome: A Comparative Analysis

  2024cites this paper
• Australasian Recurrent Pregnancy Loss Clinical Management Guideline 2024 Part I

  2024cites this paper
• Pregnancy and Nutritional Factors in Women with Polycystic Ovary Syndrome After Metabolic Surgery

  2024cites this paper
• Tri-Chromium picolinate significantly improved the hormonal levels and CYP17A1 expression in female rats induced with polycystic ovary syndrome

  2024cites this paper
• Prevalence of polycystic ovary syndrome among infertile women in the Gulf Cooperation Council (GCC) countries: A systematic review and meta-analysis

  2024cites this paper
• The investigation and management of recurrent early pregnancy loss: a Canadian Fertility and Andrology Society clinical practice guideline.

  2024cites this paper
• Endocrine Characteristics and Obstetric Outcomes of PCOS Patients with Successful IVF and Non-IVF Pregnancies

  2024cites this paper
• Placental assessment using spectral analysis of the envelope of umbilical venous waveforms in sheep.

  2023cites this paper
• Efficacy and safety of metformin in pregnant women with polycystic ovary syndrome: a systematic review with meta-analysis of randomized and non-randomized controlled trials

  2022cites this paper
• Elevated serum malondialdehyde (MDA), insulin, follicle-stimulating hormone (FSH), luteinizing hormone (LH), and thyroid- stimulating hormone (TSH), and reduced antioxidant vitamins in polycystic ovarian syndrome patients

  2022cites this paper
• PREGNANCY COMPLICATIONS AND OUTCOMES IN WOMEN WITH POLYCYSTIC OVARIAN SYNDROME

  2022cites this paper
• Cardiovascular disease risk in offspring of polycystic ovary syndrome

  2022cites this paper
• Polycystic ovarian syndrome and miscarriage in IVF: systematic revision of the literature and meta-analysis

  2022cites this paper
• Evaluation of inflammatory markers in patients diagnosed with polycystic ovary syndrome (PCOS)

  2021cites this paper
• Infertility, Infertility Treatment and Cardiovascular Disease: An Overview.

  2021cites this paper
• Effects of metformin treatment on pregnancy outcomes in patients with polycystic ovary syndrome

  2021cites this paper
• Women with PCOS with a History of Early Pregnancy Loss Show a Higher Risk of Gestational Diabetes Mellitus

  2021cites this paper
• Metformin for pregnancy and beyond: the pros and cons

  2021cites this paper
• Evaluation Follicular Fluid Cytokines in Patients with Risk Factor for Development of Ovarian Hyper Stimulation Syndrome

  2021cites this paper
• The Effect of Free Androgen Index on the Quality of Life of Women With Polycystic Ovary Syndrome: A Cross-Sectional Study

  2021cites this paper
• ASSESSMENT ON THE LEVEL OF KNOWLEDGE OF WOMEN OF REPRODUCTIVE AGE GROUP ABOUT POLYCYSTIC OVARIAN SYNDROME (PCOS) AND ITS EFFECT ON REPRODUCTIVE HORMONES

  2021cites this paper
• Knockdown of circ-FURIN suppresses the proliferation and induces apoptosis of granular cells in polycystic ovary syndrome via miR-195-5p/BCL2 axis

  2021cites this paper
• Association of genetic polymorphism of LKB/STK11 with therapeutic response of metformin in women with polycystic ovary syndrome

  2021cites this paper
• Investigation of possible effects of Exendin-4 during exposure to mild chronic stress on dehydroepiandrosterone-induced polycystic ovary syndrome in rats

  2020cites this paper
• Impact of Recurrent Miscarriage on Maternal Outcomes in Subsequent Pregnancy: The Mutaba’ah Study

  2020cites this paper
• Mitochondrial function in women with polycystic ovary syndrome.

  2020cites this paper
• Maternal and neonatal outcomes among pregnant women with different polycystic ovary syndrome phenotypes: A cross-sectional study

  2020cites this paper
• Fertility and pregnancy outcomes in women with polycystic ovary syndrome following bariatric surgery.

  2020cites this paper
• The Outcome of Laparoscopic Ovarian Drilling in Patients with Clomiphene-resistant Polycystic Ovarian Syndrome in Ogbmoso, Nigeria: A Prospective Evaluation

  2020cites this paper
• In Vitro Maturation of Human Oocytes

  2019cites this paper
• Nonpharmacologic Management of Symptoms in Females With Polycystic Ovary Syndrome: A Narrative Review

  2019cites this paper
• Awareness of polycystic ovarian syndrome among young women in Western India

  2019cites this paper
• Prenatal androgen excess alters the uterine peroxisome proliferator-activated receptor (PPAR) system.

  2019cites this paper
• Predicting the Presence of Poly Cystic Ovarian Syndrome using Classification Techniques

  2019cites this paper
• Higher chromosomal aberration rate in miscarried conceptus from polycystic ovary syndrome women undergoing assisted reproductive treatment.

  2019cites this paper
• Polycystic ovarian syndrome (PCOS) awareness among young women of central India

  2018cites this paper
• Role in Reproductive Biology and Reproductive Dysfunction in Women

  2018cites this paper
• The Effect of Supraphysiological Estradiol on Pregnancy Outcomes Differs Between Women With PCOS and Ovulatory Women

  2018cites this paper
• Application of the Apriori Algorithm for Prediction of Polycystic Ovarian Syndrome (PCOS)

  2018cites this paper
• Moderate increases in daily step count are associated with reduced IL6 and CRP in women with PCOS

  2018cites this paper
• Current aspects of polycystic ovary syndrome I: definition, pathophysiology, clinical manifestations, diagnosis and complications

  2018cites this paper
• Ведение пациенток с синдромом поликистозных яичников в интергенетическом интервале

  2017cites this paper
• Preliminary Study on Development of Pattern Identification Instrument for Polycystic Ovarian Syndrome

  2017cites this paper
• Investigation the Effect of Glycyrrhizic Acid on Ovarian Follicle in Polycystic Ovarian Syndrome Mice Model

  2017cites this paper
• Association of polycystic ovary syndrome with metabolic syndrome and gestational diabetes: Aggravated complication of pregnancy

  2017cites this paper
• Obstetric Outcome of In Vitro Maturation Treatment and Risk of Congenital Malformations

  2017cites this paper
• Effect of Obesity on Clinical Parameters and Pregnancy Rates in Women with Polycystic Ovary Syndrome Undergoing Ovulation Induction Cycles.

  2017cites this paper
• Chapter 4 Polycystic Ovary Syndrome

  2017influential citation
• Recurrent Pregnancy Loss in Patients with Polycystic Ovary Syndrome: A Case Control Study

  2017cites this paper
• Effectiveness of lifestyle modification package among overweight and obese adolescent girls between 15-19 years with polycystic ovarian syndrome

  2016cites this paper
• New Frontiers in RPL Research and Treatment

  2016cites this paper
• Complicaciones obstétricas y ginecológicas del síndrome de ovario poliquístico

  2016cites this paper
• Contemporary Reproductive Outcomes for Patients With Polycystic Ovary Syndrome: A Retrospective Observational Study

  2016cites this paper
• Developmental Programming: Prenatal and Postnatal Androgen Antagonist and Insulin Sensitizer Interventions Prevent Advancement of Puberty and Improve LH Surge Dynamics in Prenatal Testosterone-Treated Sheep.

  2015cites this paper
• Safety of Chinese herbal medicines during pregnancy

  2015cites this paper
• Polycystic ovary syndrome in contemporary India: An ethnographic study of globalization, disorder, and the body

  2015cites this paper
• Polycystisk ovariesyndrom (PCOS) Forfattere

  2015cites this paper
• RESEARCH ARTICLE EFFECT OF PERGULARIA DAEMIA IN POLYCYSTIC OVARY SYNDROME INDUCED RAT OVARIES AND THYROID GLAND

  2015cites this paper
• Getting Pregnant with PCOS

  2015cites this paper
• Confocal Microscopic Analysis of the Spindle and Chromosome Configurations of in vitro-Matured Oocytes from Different Types of Polycystic Ovary Syndrome Patients

  2015cites this paper
• Pregnancy complications in polycystic ovary syndrome patients

  2015cites this paper
• Management of Polycystic Ovary Syndrome in India

  2014cites this paper
• [Polycystic ovary syndrome: what are the obstetrical risks?].

  2014influential citation
• Academy of Medicine-Ministry of Health Clinical Practice Guidelines: assessment and management of infertility at primary healthcare level.

  2014cites this paper
• Syndrome des ovaires polymicrokystiques : une pathologie à risque obstétrical ?

  2014influential citation
• Validity and Reliability of a Korean version of Polycystic Ovary Syndrome Questionnaire.

  2014cites this paper
• The efficacy of metformin in pregnant women with polycystic ovary syndrome: A meta-analysis of clinical trials

  2013cites this paper
• The guidelines issued by the European Society for Human Reproduction and Embryology and the American Society for Reproductive Medicine regarding the induction of ovulation with metformin in patients with the polycystic ovary syndrome potentially require reconsideration

  2013cites this paper
• Outcome of Laparoscopic Ovarian Drilling in Patients of Clomiphene Resistant Polycystic Ovarian Syndrome in a Tertiary Care Center

  2013cites this paper
• Pregnancy in polycystic ovary syndrome

  2013cites this paper
• Risks for Gestational Diabetes Mellitus and Pregnancy-Induced Hypertension Are Increased in Polycystic Ovary Syndrome

  2013cites this paper
• Independent association of the M2/ANXA5 haplotype with recurrent pregnancy loss (RPL) in PCOS patients.

  2013cites this paper
• Two-hour insulinemia after oral glucose overload and women at risk of pregnancy-induced hypertensive disorders

  2013cites this paper
• Appropriate use of metformin in early pregnancy: is there a role for first trimester use?

  2013cites this paper
• A polycystás ovárium szindrómában a táplálkozás szerepe a cukorbetegség kialakulásának megelőzésében és a terápiás lehetőségek kiegészítésében

  2013cites this paper
• The frequency of insulin resistance and hyperlipidaemia in women with Polycystic Ovarian Syndrome ( PCOS ) attending

  2012cites this paper
• Female Obesity and Assisted Reproductive Technologies

  2012cites this paper
• Metformina e o papel no tratamento da infertilidade em mulheres com síndrome do ovário poliquistico.

  2012cites this paper
• Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group.

  2012cites this paper
• Habituelle Abortneigung

  2012cites this paper
• Protein expression of PKCZ (Protein Kinase C Zeta), Munc18c, and Syntaxin-4 in the insulin pathway in endometria of patients with polycystic ovary syndrome (PCOS)

  2012cites this paper
• Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview

  2012cites this paper
• Embryoprotective Therapy of Infertile Women with Polycystic Ovary Syndrome

  2012cites this paper
• Polycystic Ovary Syndrome (PCOS): Making Sense of the Alphabet

  2011cites this paper
• Prenatal testosterone-induced fetal growth restriction is associated with down-regulation of rat placental amino acid transport

  2011influential citation
• Vitamin D: Relevance in Reproductive Biology and Pathophysiological Implications in Reproductive Dysfunction

  2011cites this paper
• Influência da diminuição da temperatura sobre o fuso meiótico de oócitos de camundongas e de mulheres maturados in vitro

  2011cites this paper
• Effect of body mass index on IVF treatment outcome: an updated systematic review and meta-analysis.

  2011cites this paper
• Reproductive medicine and inheritance of infertility by offspring: the role of fetal programming.

  2011cites this paper
• Relationship between Recurrent Miscarriage and Insulin Resistance

  2011cites this paper
• RETRACTED ARTICLE: Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome? Prospective cohort study

  2011cites this paper
• Sex Steroid Hormones and Reproductive Disorders

  2011cites this paper
• Current perspectives of insulin resistance and polycystic ovary syndrome

  2011cites this paper
• Use of metformin before and during assisted reproductive technology in non-obese young infertile women with polycystic ovary syndrome: a prospective, randomized, double-blind, multi-centre study.

  2011cites this paper
• The role of continuing metformin therapy during pregnancy in the reduction of gestational diabetes and improving pregnancy outcomes in women with polycystic ovary syndrome

  2011cites this paper
• The frequency of insulin resistance and hyperlipidaemia in women with polycystic ovarian syndrome (PCOS) attending Inkosi Albert Luthuli Central Hospital .

  2010cites this paper